Various Predictors of Sustained Virologic Response in Different Age Groups of Patients With Genotype-1 Chronic Hepatitis C

被引:3
作者
Lin, Chun-Yen [1 ,3 ]
Sheen, I-Shyan [1 ,3 ]
Chen, Ji-Yih [2 ,3 ]
Huang, Chang-Wen [1 ]
Huang, Chien-Hao [1 ]
Jeng, Wen-Juei [1 ]
Chen, Wei-Ting [1 ]
机构
[1] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Gastroenterol & Hepatol, Tao Yuan 333, Taiwan
[2] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Rheumatol Allergy & Immunol, Tao Yuan 333, Taiwan
[3] Chang Gung Univ, Coll Med, Sch Med, Tao Yuan 333, Taiwan
关键词
chronic hepatitis C; sustained virologic response; IL28B polymorphism; predictor; age; INTERFERON-ALPHA-2B PLUS RIBAVIRIN; PEGINTERFERON ALPHA-2A; TREATMENT DURATION; GENETIC-VARIATION; HCV GENOTYPE-2; OLDER PATIENTS; IL28B; POLYMORPHISMS; IDENTIFICATION; INFECTION;
D O I
10.1097/MCG.0b013e31829d2064
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background:Age is one of the sustained virologic response (SVR) predictors for genotype-1 chronic hepatitis C patients treated with pegylated interferon-/ribavirin. However, variation of SVR predictors in different age groups was not explored before. We therefore conducted this study for investigating this issue.Methods:We retrospectively analyzed 265 genotype-1 chronic hepatitis C patients who received pegylated interferon-/ribavirin treatment. These patients were divided into 3 age groups. Clinical parameters including the genotype of rs12979860 were analyzed.Results:SVR rate was highest in patients younger than 45 years and lowest in patients older than 65 years even through propensity score matching analysis. As for rapid virologic response (RVR) predictors, genotype of rs12979860 was the predictor for the patients younger than 45 years and patients aged between 45 and 65 years, but no RVR predictor was found for patients older than 65 years. As for the SVR predictors, HbA1c, baseline viral load, and RVR but not genotype of rs12979860 were the predictors in patients younger than 45 years. For patients between 45 and 65 years, the predictors for SVR were liver fibrosis, genotype of rs12979860, and RVR. For patients older than 65 years, RVR was the only predictor for SVR.Conclusions:SVR predictors are various in different age groups. RVR is the SVR predictor for all age groups, but the genotype of rs12979860 is the SVR predictor only for patients with age between 45 and 65 years but not younger or older patients.
引用
收藏
页码:794 / 799
页数:6
相关论文
共 42 条
[1]   Hepatitis C Pharmacogenetics: State of the Art in 2010 [J].
Afdhal, Nezam H. ;
McHutchison, John G. ;
Zeuzem, Stefan ;
Mangia, Alessandra ;
Pawlotsky, Jean-Michel ;
Murray, Jeffrey S. ;
Shianna, Kevin V. ;
Tanaka, Yasuhito ;
Thomas, David L. ;
Booth, David R. ;
Goldstein, David B. .
HEPATOLOGY, 2011, 53 (01) :336-345
[2]   The natural history of hepatitis C [J].
Afdhal, NH .
SEMINARS IN LIVER DISEASE, 2004, 24 :3-8
[3]   NK Cells in Healthy Aging and Age-Associated Diseases [J].
Camous, Xavier ;
Pera, Alejandra ;
Solana, Rafael ;
Larbi, Anis .
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2012,
[4]   IL28B genetic variations are associated with high sustained virological response (SVR) of interferon-α plus ribavirin therapy in Taiwanese chronic HCV infection [J].
Chen, J-Y ;
Lin, C-Y ;
Wang, C-M ;
Lin, Y-T ;
Kuo, S-N ;
Shiu, C-F ;
Chang, S-W ;
Wu, J. ;
Sheen, I-S .
GENES AND IMMUNITY, 2011, 12 (04) :300-309
[5]  
Cusack Barry J, 2004, Am J Geriatr Pharmacother, V2, P274, DOI 10.1016/j.amjopharm.2004.12.005
[6]  
D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO
[7]  
2-B
[8]   Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response [J].
Ferenci, Peter ;
Laferl, Hermann ;
Scherzer, Thomas-Matthias ;
Gschwantler, Michael ;
Maieron, Andreas ;
Brunner, Harald ;
Stauber, Rudolf ;
Bischof, Martin ;
Bauer, Bernhard ;
Datz, Christian ;
Loeschenberger, Karin ;
Formann, Elisabeth ;
Staufer, Katharina ;
Steindl-Munda, Petra .
GASTROENTEROLOGY, 2008, 135 (02) :451-458
[9]  
Ferrucci LSS, 2013, HARRISONS PRINCIPLES
[10]   Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. [J].
Fried, MW ;
Shiffman, ML ;
Reddy, KR ;
Smith, C ;
Marinos, G ;
Goncales, FL ;
Haussinger, D ;
Diago, M ;
Carosi, G ;
Dhumeaux, D ;
Craxi, A ;
Lin, A ;
Hoffman, J ;
Yu, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) :975-982